Previous |
Next Pfizer Is Ordered to Pay $850,000 to Brigham Young U. for Delaying Patent Litigation |
October 28, 2009, 06:12 PM ET
2 Reports Highlight Value of University Licenses to Biotech Industry
A new study released today by the Biotechnology Industry Organization, a biotechnology-industry trade group known as BIO, estimates that licensing deals for university-developed inventions contributed $47-billion to $182-billion cumulatively to the U.S. gross domestic product from 1996 through 2007. In a separate survey by BIO of 150 biotechnology companies, also released today, a majority said they depended heavily on licenses with universities, particularly because those institutions are less restrictive than federal agencies in their willingness to grant exclusive licenses.
Add Your Comment
You must be logged in to add a comment. Please login now or create a free account.